Do all cases of ILD, even the most typical ones, need to be discussed in an MDT?

Should MDTs deal with management (in addition to diagnosis)?

Is the presence of both a rheumatologist and a pulmonologist always required when discussing a case of CTD-ILD?

What constitutes the quorum in an MDD?

Which method of lung biopsy should be used?

What data should be presented in an MDT?

What is the frequency of an MDT meeting?

What is the potential role in MDD of noncore members (e.g. palliative care specialist, research nurse and physiologist)?

Does the MDT have a role in other scenarios, e.g. assessment of longitudinal disease behaviour?